diabetestalk.net

Lilly Diabetes Facebook

Brickyard 400 Tickets

Brickyard 400 Tickets

View Ticket Prices | View Seating Map | View Race Day Schedule Beginning in January 2018, a $3 service fee will apply to each ticket or wristband purchased for an IMS racing or concert event (excluding practice and qualifications). The handling fee applied to each order will be reduced from $9 to $5 and will be waived for print-at-home orders, when available. Find and reserve your seats for the Big Machine Vodka 400 at the Brickyard Powered by Florida Georgia Line today before theyre gone! Each seat offers you a unique experience and breathtaking action that only the Indianapolis Motor Speedway can deliver. Reserved Seats also grant you access to General Admission areas throughout IMS. Find and reserve your seats for the Big Machine Vodka 400 at the Brickyard Powered by Florida Georgia Line today before theyre gone! Each seat offers you a unique experience and breathtaking action that only the Indianapolis Motor Speedway can deliver. Reserved Seats also grant you access to General Admission areas throughout IMS. The most affordable way to enjoy the Big Machine Vodka 400 at the Brickyard Powered by Florida Georgia Line is with General Admission. Enjoy the race from numerous available locations within the Indianapolis Motor Speedway infield. Dont forget children 15 & under are free with a paid Adult General Admission ticketholder. The most affordable way to enjoy the Big Machine Vodka 400 at the Brickyard Powered by Florida Georgia Line is with General Admission. Enjoy the race from numerous available locations within the Indianapolis Motor Speedway infield. Dont forget children 15 & under are free with a paid Adult General Admission ticketholder. Get close to the action at the Big Machine Vodka 400 at the Brickyard Powered by Florida Georgia Line with pre-race Pit Passe Continue reading >>

Eli Lilly Honors Diabetes Patients At Diabetes Journey Awards

Eli Lilly Honors Diabetes Patients At Diabetes Journey Awards

Eli Lilly honors diabetes patients at Diabetes Journey Awards Indeed, before insulin was developed in the 1920s, patients diagnosed with diabetes rarely lived beyond childhood. Eli Lilly honors diabetes patients at Diabetes Journey Awards Indeed, before insulin was developed in the 1920s, patients diagnosed with diabetes rarely lived beyond childhood. Check out this story on courierpress.com: A link has been sent to your friend's email address. A link has been posted to your Facebook feed. Eli Lilly honors diabetes patients at Diabetes Journey Awards Annie Adelman , [email protected] Published 7:00 p.m. CT April 23, 2017 Eli Lilly and Company presented the Lilly Diabetes Journey Awards to 25 individuals at Deaconess on Thursday evening. Deaconess Chief Medical Officer Dr. Mack Blanton spoke at the awards ceremony. Before insulin was developed in the 1920s, patients diagnosed with type 1 diabetes rarely lived beyond childhood. Now, Eli Lilly celebrates patients who have managed their type 1 diabetes with the Lilly Diabetes Journey Awards . The pharmaceutical company has presented these awards to patients since 1975, but a ceremony earlier this month was the first time they presented them at Deaconess Hospital. "It's honoring patients who have managed their diabetes for a long time," Deaconess Chief Medical Officer Dr. Mack Blanton said."Those patients who have been doing it for many, many years have managed their diabetes well because it can be a devasting disease with a lot of complications." Awards were given to patients who have managed their diabetes for 10, 25 and 50 years. One award recipientwas Tara Gray from McLeansboro, Illinois, who found out she had type 1 diabetes when she was five. "Mom said I was just thirsty all the time and went to the bathro Continue reading >>

So, I Am Mad About The Recent Eli Lilly... - Diabetesmine.com | Facebook

So, I Am Mad About The Recent Eli Lilly... - Diabetesmine.com | Facebook

So, I am MAD about the recent Eli Lilly list price increase of 7.8% on Humalog + Humulin (and glucagon, btw). Fired off an email to Lilly Diabetes PR on Wednesday night and another on Thursday morning, frustrated and angry but also trying to see through my red-tinged vision to be as reasonable and rationale on this as possible. Lilly's PR lead Julie Williams called on Thursday, and we had an hour-long conversation. I was not happy, and said so. Felt like this was a slap in the face, as it so closely followed the Access Workshop and made the whole get-together seem like a PR stunt. That despite my recognition that there's more to this -- and what was discussed on April 20 is important and a huge aspect of this Insulin Affordability & Access Crisis -- I am very much struggling with staying calm and rationale and reasonable in discussing this. And I don't know if I really care or believe what what they say at this point. #DoubtWhatTheySay #BelieveWhatTheyDo . That being said, Julie's responses were what you might expect -- and I 95% believe they were genuine, and at least the workshop-attending folk and PR team were completely caught off guard by this recent list price. Still, I'm not sure that matters very much anymore. I'll plan to write more on this at DiabetesMine soon enough, but have asked some pointed questions that I am expecting answers on by EOB today. And assuming some will be boiler-plate PR responses, I will press on as needed until I get a response I feel is adequate (even if the question can't legally/otherwise be answered as I'd prefer). So, these are those Qs... 1. As to this my earlier Q that you rephrased about what Lilly could have done better or sooner -- My exact question was What Responsibility Does Lilly Bear in our current Insulin Affordability an Continue reading >>

Lilly Diabetes Pulls Logos From Conor Daly Over Father's Slur

Lilly Diabetes Pulls Logos From Conor Daly Over Father's Slur

Lilly Diabetes' long anticipated sponsorship of Conor Daly's NASCAR debut disappears Dave Kallmann , Milwaukee Journal Sentinel Published 7:02 p.m. CT Aug. 24, 2018 | Updated 10:11 p.m. CT Aug. 24, 2018 Conor Daly, in the No. 6 Roush Fenway Racing Ford, leads Spencer Boyd in practice Friday for Saturday's Johnsonville 180, Daly's NASCAR Xfinity Series debut. CONNECT TWEET LINKEDIN 1 COMMENTEMAILMORE ELKHART LAKE - In looking to avoid a distraction, Lilly Diabetes may have created a larger one. Lilly announced in May it would sponsor Conor Daly in his NASCAR Xfinity Series debut with Roush Fenway Racing at Road America, along withteammates Ryan Reed and Ty Majeski. Reed and Daly have diabetes, as does Majeskis maternal grandfather. But when Daly took to the track Friday for Johnsonville 180 practice, it didn't have the Lilly logos and was black, green and white rather than red, white and gray. Lilly issued the following statement, referencing a slur used 33 years ago by Derek Daly, Conors father, that led to the elder Dalys firing by an Indianapolis TV station: Our sponsorship in Saturdays race is intended to raise awareness of treatment options and resources for people living with diabetes. Unfortunately, the comments that surfaced this week by Derek Daly distract from this focus, so we have made the decision that Lilly Diabetes will no longer run the No. 6 at Road America this weekend. We remain committed to our mission of supporting people with diabetes. Continue reading >>

Flat Tires Leaves Reed With A 19th-place Finish In Vegas | Ryan Reed

Flat Tires Leaves Reed With A 19th-place Finish In Vegas | Ryan Reed

FLAT TIRES LEAVES REED WITH A 19TH-PLACE FINISH IN VEGAS LAS VEGAS, Nev. (March 3, 2018) Ryan Reed qualified his No. 16 Drive Down A1C Lilly Diabetes Ford 13that Las Vegas Motor Speedway and was poised for a solid top-10 finish until a flat tire derailed his efforts. Reed was able to only lose one lap and salvage a 19th-place finish Saturday afternoon in Vegas. I feel like we had an outside shot at a top-10 and it sucks we tore it up a little bit, said Reed. We have to get better at the smooth 1.5 mile tracks. I think we had more speed at Atlanta. Our Ford Mustang has a little bit of work to do but we will get there. The No. 16 was a little tight over the first 45-lap Stage, but Reed was able to maneuver his way around the 1.5-mile track and close out the first Stage 11th. Reed came down pit road at the conclusion of the Stage for four tires, fuel and a track bar adjustment. The jack broke on the stop, costing time on pit road, which left Reed starting Stage 2 from 16th. Over the course of Stage 2 the handling shifted to extremely loose and by the conclusion of the Stage Reed was 19thand ready for some chassis adjustments. Crew chief Phil Gould made a big swing with handling before the start of the final Stage with packer, track bar and air pressure adjustments. Reed started the final Stage 17thand steadily began working his way through the field. While running 12thwith 16 laps remaining the right front tire went flat on the No. 16 Ford, resulting in an unscheduled trip down pit road for repairs. The team was able to change the tires and get Reed back on track just one lap down. Despite having some damage to his Ford, Reed was able to drive his No. 16 Drive Down A1C Ford to a 19th-place finish. Lilly has been a global leader in diabetes care since 1923, when we introdu Continue reading >>

Introdia Survey | Boehringer-ingelheim.com

Introdia Survey | Boehringer-ingelheim.com

*Please note these countries included fewer than 50 participants Additional country statistics are available upon request IntroDia is the largest multi-national survey to date investigating early conversations between physicians and people with T2D. It includes insights from 6,753 physicians and 10,139 people with T2D from 26 countries. The survey focuses on two potentially pivotal time points in T2D management: diagnosis and the add-on moment, when additional oral medication is introduced. The IntroDia surveys physician insights and patient findings will be used to develop solutions that help shape the early T2D conversations and ultimately improve quality of care. IntroDia is an initiative of Boehringer Ingelheim and Eli Lilly and Company in partnership with the International Diabetes Federation. It has been developed in collaboration with an international, multidisciplinary Advisory Board of T2D experts from the field of primary care, endocrinology, behavioural psychology, nursing and diabetes education including: Ms. Anne Belton, Canada; Dr. William Polonsky, USA; Dr. Steven Edelman, USA; Dr. Matthew S. Capehorn, UK and Ms. Susan Down, UK, Prof. Aus Alzaid, Saudi Arabia. For more details, please visit www.introdia.com Boehringer Ingelheim and Eli Lilly and Company In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in diabetes that centres on compounds representing several of the largest diabetes treatment classes. This alliance leverages the strengths of two of the worlds leading pharmaceutical companies. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com . Boehr Continue reading >>

Patients Beg For Pricey Drugs On Facebook Black Market

Patients Beg For Pricey Drugs On Facebook Black Market

Desperate patients are swapping pricey pharmaceutical drugs on Facebook. Doctors say it's dangerous. But when you need a drug every day to survive, you're going to find a way to get it. It shouldn't be that surprising. You can buy, sell or trade almost anything on Facebook, from designer sneakers to unwanted fishing boats to antique medical cots. Now, even life-saving insulin. Financially struggling patients know they're taking a risk when they inject something sent by a Facebook "friend" into their body. But they say without affordable alternatives they're forced to rely on this online honor system. "I Would be Dead" Here's how it works. Patient with diabetes, for instance, might post a request for help to their regular Facebook newsfeed. It's like tossing an SOS in a bottle into cyberspace. Then there are the dedicated Facebook groups set up to arrange trades. "In need of Lantus will trade Novolog," read a post in one of the forums. "I have Lantus pen and I'll trade you as I need Novolog! PM [private message] me," said one of the replies. Another reply suggested the shipper use "a frozen juice box or ice pack" to keep the biopharmaceutical refrigerated. "ISO [in search of] a Novopen Echo. I have Humalog and Apidra pens and Apidra vials and Ominpods to trade," read another post. A match was made when another forum member replied, "I have one with some unexpired Novolog refills. I am in need of Apidra pens!" Membership in the mostly private groups may require moderator approval. NBC News reporters requested to join and were admitted to some of the groups. Their member numbers can range from a few dozen to a couple thousand. The posts take various forms. Sometimes a patient asks for help when they've run out of supplies, insurance coverage and/or money. Another person wh Continue reading >>

The Best Diabetes Blogs Of The Year

The Best Diabetes Blogs Of The Year

We’ve carefully selected these blogs because they are actively working to educate, inspire, and empower their readers with frequent updates and high-quality information. If you would like to tell us about a blog, nominate them by emailing us at [email protected]! Diabetes is one of the largest health issues facing Americans today. More than 29 million adults in the U.S. have diabetes — and almost one quarter of them don’t know they have it. A further 86 million adults in the U.S. have prediabetes, a condition which increases your risk of developing type 2 diabetes. A whopping 90 percent of these people are unaware of that, too. Both forms of diabetes — type 1 and type 2 — are chronic conditions, meaning they require a lifetime of careful treatment to be properly managed. If left untreated or improperly managed, diabetes can cause serious health complications. For those living with diabetes, the condition can be isolating and take up a significant amount of time as well as mental and emotional energy. Staying on top of your treatments can also be challenging, as everyday things can make a big impact on blood glucose readings, and treatment options are always changing. That’s why we’ve rounded up the best diabetes blogs out there. Whether you’re looking for recipes, resources, treatment options, or simple tips for living well, you’re sure to find something here for you. Diabetes Self-Management Blog Diabetes Self-Management has provided health information to the diabetes community for over 35 years. Their companion blog rounds up tips and info from both healthcare professionals and people living with diabetes. Posts range from hard-hitting news to tips and information you can use, like busting myths about grain. There are also personal stories, to Continue reading >>

'an Escalating Crisis': People With Diabetes Struggle To Afford Life-saving Insulin

'an Escalating Crisis': People With Diabetes Struggle To Afford Life-saving Insulin

The high cost of insulin for Jessica Price, diagnosed with type 1 diabetes mellitus as a child sometimes leaves her with difficult life choices, Wednesday, Sept. 6, 2017. Michelle Pemberton/IndyStar ​​​​​​For the first two decades that Jessica Price had diabetes, she never worried about the price of her insulin and supplies, because her mother’s insurance covered the cost. Then she switched to her employer’s high-deductible insurance plan. All of the sudden, she was facing bills of a few thousand dollars each time she went to the pharmacy to purchase her supplies for the next three months. “It’s never a question of if I’m going to hit my deductible, but a question of how quickly can I hit it,” said Price, who works for a nonprofit and has found herself having to borrow from her parents to help with the bills. “If I don’t hit my deductible until June or July, I start to worry.” ► In other Lilly news: Lilly CEO says 3,500 job cuts will make company healthier, stronger ► More: No fertility treatments, but multiple surprises. It's quadruplets for Noblesville couple. ► More: Think you need to go to ER? If your insurer doesn't agree, you could pay Increasingly over the past decade, people with diabetes such as Price find themselves saddled with hefty bills for the insulin they require to survive. Of the 6 million or people in the United States who depend on insulin, about 1.25 million of those are people who have Type I diabetes, a condition in which their pancreases don’t produce the hormone insulin, according to the American Diabetes Association. The remainder have Type II diabetes and take insulin to help out their bodies, which do not produce sufficient insulin on their own. Historically, obtaining sufficient insulin did not require t Continue reading >>

Rimidi And Lilly Collaborate To Personalize Solutions For People Using Insulin

Rimidi And Lilly Collaborate To Personalize Solutions For People Using Insulin

Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin Companies will strive to make diabetes management easier through effective use of connected devices and a diabetes management software platform INDIANAPOLISandATLANTA,Dec. 14, 2017/PRNewswire/ Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, andEli Lilly and Company(NYSE: LLY), a leader in diabetes care for more than 90 years, are coming together to develop provider-focused tools that will integrate personalized solutions for people who use insulin to manage their diabetes, the companies announced today. Rimidi will integrate its diabetes management software platform with Lillys integrated insulin management system in development. The non-exclusive agreement between Rimidi and Lilly will strive to make diabetes management easier for approximately 30 million Americans with diabetes and the health care providers who care for them by helping people use insulin more effectively while optimizing diabetes management within the normal clinical workflow. Diabetes management is a collaborative effort between people with diabetes and their healthcare providers. With the right support they can achieve better results together, saidLucienne Ide, MD, PhD and CEO of Rimidi. We are proud to partner with Lilly to facilitate personalized management of diabetes. This is a better together story. Rimidis platform helps clinicians personalize care by leveraging the individual characteristics and clinical histories of people with diabetes to identify individuals who may benefit from specific management approaches. Lillys integrated insulin management system combines a connected insulin pen with glucose-sensing technologies (e.g., glucose meter, CGM) and Continue reading >>

Livongo And Lilly Collaborate On Real-world Diabetes Research

Livongo And Lilly Collaborate On Real-world Diabetes Research

Livongo and Lilly Collaborate on Real-World Diabetes Research Companies join forces to advance predictive and prescriptive recommendations for people with diabetes INDIANAPOLIS and MOUNTAIN VIEW, CA, January 8, 2018 Eli Lilly and Company (NYSE: LLY) and Livongo Health, a leading consumer digital health company focused on empowering all people with chronic conditions to live better and healthier lives, today announced a strategic collaboration to study real-world evidence and develop new insights to reduce the burden on people living with diabetes. The research collaboration will combine real-world behavioral studies and claims data to advance knowledge about effective interventions in diabetes care. The companies aim to contribute to medical literature in three areas: Measure the impact of remote diabetes self-management education and support on clinical and healthcare cost outcomes Understand how people living with diabetes can stay more actively involved in their health Lilly has been a leader in diabetes care for more than 90 years, and was the first company to make insulin commercially available to people with the disease. Today, Lilly provides a wide range of therapies to address the diverse needs of people living with diabetes. Collaborating with Livongo is an important step in our research efforts, said Sherry Martin, MD, vice president of Medical Affairs, Lilly Diabetes.We hope that our combined expertise will play a key role in empowering people with diabetes to better manage their condition. Livongo is redesigning chronic condition management, starting with diabetes. Livongo delivers a personalized experience, using data and clinical science, and helps to make staying healthy easier, which results in measurable positive health outcomes for people with diabete Continue reading >>

Whats Next For Diabetes Care In Germany?

Whats Next For Diabetes Care In Germany?

Whats next for diabetes care in Germany? Todays guest blog comes from Dr. Gerd Kraeh, Senior Director Government Affairs at Lilly Germany We at Lilly Germany are committed to improve the conditions of people living and working with diabetes. This is why we developed the [email protected] initiative. Two weeks before the German elections, the partners of [email protected] seized the chance to push the topic of diabetes even higher on the political agenda for the upcoming legislative period. Specifically, we discussed key aspects of a modern and patient-centered diabetes care with one of Germanys most influential political health care experts and Parliamentary State Secretary at the Federal Ministry of Finance Jens Spahn. Along with representatives from labour unions, sick funds, regional companies and physicians, we looked ahead and discussed the essential post-election health policy initiatives. What are the next health policy steps towards a more innovative diabetes care? Paving the way for digital care solutions will be one of the top priorities of the new health policy agenda. Innovative applications can encourage people to have a healthier lifestyle and support patients in managing their diabetes. For example, connecting smartphones with insulin pumps for continuous and transparent glucose monitoring. Big data will also spur advances in diagnosis and individualized therapies. However, to tap the full potential of digital innovations, policymakers and sick funds need to provide stronger incentives to implement digital care services. To transform diabetes care, the roll-out of connected solutions must be politically supported and should be integrated in a holistic political approach towards diabetes. One positive step forward would be the creation of a national diabetes stra Continue reading >>

Inside The Lilly Diabetes Blogger Summit

Inside The Lilly Diabetes Blogger Summit

Editors Note: Beyond Type 1 Global Ambassador Council Member + T1D Libby Russell attended the Lilly Diabetes Blogger Summit, where the company debuted new tech developments. This piece represents Libbys view on whats new from Lilly, with her personal responses as a person living with Type 1 diabetes. Lilly Diabetes paid for Libbys travel. This effort is not just about developing the latest in insulin delivery technology. Its about unlocking a diabetes therapy that addresses the holistic needs of a person with diabetes that will actually make their life easier, and better. Matt Clemente, CTO, Delivery, Devices & Connected Solutions at Eli Lilly and PWD. This month, a special team within Lilly Diabetes hosted a small group of diabetes bloggers from around the country to participate in a 2-day summit at their new innovation center in Cambridge, Massachusetts. At this summit, a team consisting of both technology and scientific leaders as well as partners from the biotech industry announced that Lilly Diabetes is throwing their hat in the ring to keep pushing the capabilities of the closed loop insulin delivery system. As a refresher for those of you (like me) who are dinosaurs about these kinds of things a closed loop system is an ecosystem of diabetes treatment where an insulin pump (or pen) and continuous glucose monitor work together in tandem to manage the amount of insulin and/or glucagon that is being delivered into your system based on continuous glucose readings. In a perfect world, the algorithm that runs the system will help you monitor your blood sugar levels with little to no input as the patient. The idea is that its set to cruise control, and that you can sit back, relax, and enjoy your life with a little less device maintenance overload, and a little more pe Continue reading >>

Lilly Diabetes Pulls Conor Daly's Sponsorship For Nascar Race Over Father's Comment

Lilly Diabetes Pulls Conor Daly's Sponsorship For Nascar Race Over Father's Comment

Lilly Diabetes pulls Conor Daly's sponsorship for NASCAR race over father's comment Lilly Diabetes pulls Conor Daly's sponsorship for NASCAR race over father's comment Lilly Diabetes pulls Conor Daly's sponsorship for NASCAR race over father's comment | 13 WTHR Indianapolis Conor Daly unveiled on Friday, May 11, 2018, a Lilly Diabetes sponsorship for the 2018 Indy 500 and NASCAR Xfinity race at Road America. (WTHR Photo/Rich Nye) Lilly Diabetes has reportedly pulled its sponsorship of Conor Daly in this weekend's Xfinity Series race at Road America over comments his father made more than 30 years ago. NASCAR beat reporter Chris Knight tweeted a statement from Lilly Diabetes, announcing they were pulling their sponsorship of Daly's car in Saturday's Johnsonville 180: Our sponsorship in Saturdays race is intended to raise awareness of treatment options and resources for people living with diabetes. Unfortunately, the comments that surfaced this week by Derek Daly distract from this focus, so we have made the decision that Lilly Diabetes will no longer run the No. 6 at Road America this weekend. "We remain committed to our mission of supporting people with diabetes. Derek Daly said allegations he used a racist comment are "not only factually incorrect, but offensive." In an interview with 13 Investigates Thursday, Daly responded to WISH-TV severing ties with him and the allegation that former Colts broadcaster Bob Lamey claimed Daly used the n-word back in the 1980s. "I do not deny that I used the 'n-word,' but I think it's really important to understand the context of how it was used," Daly said. "I was new to America - this is the early '80s - 1983, I believe, maybe 84, but I think it was 83. I'm being interviewed by Larry Henry at WIBC, talking about the big changes in Continue reading >>

Conor Daly Road America Advance

Conor Daly Road America Advance

Team: No. 6 Drive Down A1C Lilly Diabetes Ford Mustang PR Contact: Nancy Padula; [email protected] ; 704-743-3940 Twitter: @ConorDaly22, @Roush6TeamNXS and @RoushFenway Ive had a lot of experience at Road America in the past. Ive won there in Skip Barber National Championship, won there in Pro Mazda and been on the podium there in sports cars. Ive had good runs there in IndyCar as well. Its been a lot of fun and Ive always enjoyed going there. There are a lot of incredible race fans there. This is obviously going to be a whole new experience for me with a very steep learning curve, but Im excited for the challenge. Ive got two good teammates to try and learn from and hope to just get up to speed as quick as we can and just have a good race day. I dont like to set expectations, just want to try and learn as much as I can and get a good finish, whatever that might be at the end of the day. Daly has two IndyCar Series starts at Road America. His best finish came in 2017 where he started 21st and finished 15th. In 2015, Daly started second and finished first in the Weathertech SportsCar Championship. Watch the Road to Road America YouTube series for an inside look of Conor preparing to make his NASCAR Xfinity Series debut this weekend. Conor Daly, Ryan Reed and Lilly Diabetes are encouraging and motivating NASCAR fans to better manage their diabetes by visiting www.DriveDownA1C.com to learn more about resources and treatment options. Lilly has been a global leader in diabetes care since 1923, when we introduced the worlds first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for Continue reading >>

More in diabetes